Francesco Mola
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Andes virus-associated cardiopulmonary syndrome: diagnostic approaches, clinical management, and evidence gaps-a scoping review.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: May 20, 2026
Corrigendum to "A naturalistic retrospective evaluation of the utility of pharmacogenetic testing based on CYP2D6 and CYP2C19 profiling in antidepressants treatment in a cohort of patients with major depressive disorder" [Progress in Neuropsychopharmacology and Biological Psychiatry (2025) 111292].
Journal: Progress in neuro-psychopharmacology & biological psychiatry
Published: July 22, 2025
Association of pharmacodynamic genes with treatment outcomes in major depressive disorder: results from a Sardinian cohort.
Journal: The pharmacogenomics journal
Published: February 24, 2025
A naturalistic retrospective evaluation of the utility of pharmacogenetic testing based on CYP2D6 e CYP2C19 profiling in antidepressants treatment in a cohort of patients with major depressive disorder.
Journal: Progress in neuro-psychopharmacology & biological psychiatry
Published: October 07, 2024
Clinical Outcome and 7-Day Virological Clearance in High-Risk Patients with Mild-Moderate COVID-19 Treated with Molnupiravir, Nirmatrelvir/Ritonavir, or Remdesivir.
Journal: Infectious diseases and therapy
Published: April 04, 2024
Correction to: Using sentiment analysis to evaluate the impact of the COVID-19 outbreak on Italy's country reputation and stock market performance.
Journal: Statistical methods & applications
Published: June 26, 2023
Using sentiment analysis to evaluate the impact of the COVID-19 outbreak on Italy's country reputation and stock market performance.
Journal: Statistical methods & applications
Published: March 12, 2023
Cost-Utility Analysis of Pharmacogenetic Testing Based on CYP2C19 or CYP2D6 in Major Depressive Disorder: Assessing the Drivers of Different Cost-Effectiveness Levels from an Italian Societal Perspective.
Journal: Clinical drug investigation
Published: July 03, 2022
Declining Mortality Rate of Hospitalised Patients in the Second Wave of the COVID-19 Epidemics in Italy: Risk Factors and the Age-Specific Patterns.
Journal: Life (Basel, Switzerland)
Published: August 06, 2021
Protocol for a pharmacogenetic study of antidepressants: characterization of drug-metabolizing profiles of cytochromes CYP2D6 and CYP2C19 in a Sardinian population of patients with major depressive disorder.
Journal: Psychiatric genetics
Published: July 20, 2021
Reliability, responsiveness and minimal clinically important difference of the two Fear Avoidance and Beliefs Questionnaire scales in Italian subjects with chronic low back pain undergoing multidisciplinary rehabilitation.
Journal: European journal of physical and rehabilitation medicine
Published: May 19, 2020
Last Updated: 09/26/2026